Loading
A phase 3 trial of Cediranib, FOLFOX, Leucovorin, Oxaliplatin, Fluorouracil and CAPOX in Colorectal cancer, run by AstraZeneca, completed.
Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer is a phase 3 interventional study registered as NCT00399035 by AstraZeneca, with 1254 participants recorded, started 2006-11 and reaching its primary completion in 2010-03. Interventions recorded: Cediranib, FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin), XELOX (Capecitabine and Oxaliplatin), Cediranib Placebo. Conditions recorded: Metastatic Colorectal Cancer.
Linked to the drug Cediranib because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
Numbers are from the trial as recorded here; see the source links in the table below. This is orientation, not medical advice: ask your team how closely the trial population matches you.
1,254 enrolled.
IQR 5.5 to 12.1; Figures from the ClinicalTrials.gov results section (first posted 2012-10-30), not from a publication · IQR 4.1 to 11.1
SourceIQR 11.0 to 36.1; Figures from the ClinicalTrials.gov results section (first posted 2012-10-30), not from a publication · IQR 11.0 to 28.9
SourceFigures from the ClinicalTrials.gov results section (first posted 2012-10-30), not from a publication
SourceShares Leucovorin (folinic acid), Oxaliplatin, Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
Shares Cediranib, AstraZeneca and the tag pipeline.
Shares Leucovorin (folinic acid), Oxaliplatin, Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), AstraZeneca and the tag pipeline.
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Oxaliplatin and the tag pipeline.
Shares Leucovorin (folinic acid), Oxaliplatin, Colorectal cancer and the tag pipeline.
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.